BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26443934)

  • 1. Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk.
    Huang YT; Yang HI; Liu J; Lee MH; Freeman JR; Chen CJ
    Epidemiology; 2016 Jan; 27(1):14-20. PubMed ID: 26443934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediation effect of hepatitis B and C on mortality.
    Huang YT; Freeman JR; Yang HI; Liu J; Lee MH; Chen CJ
    Eur J Epidemiol; 2016 Jun; 31(6):625-33. PubMed ID: 26792787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.
    Tanaka H; Tsukuma H; Yamano H; Oshima A; Shibata H
    Int J Cancer; 2004 Dec; 112(6):1075-80. PubMed ID: 15386355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.
    Chen CL; Yang HI; Yang WS; Liu CJ; Chen PJ; You SL; Wang LY; Sun CA; Lu SN; Chen DS; Chen CJ
    Gastroenterology; 2008 Jul; 135(1):111-21. PubMed ID: 18505690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
    Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.
    Wang CS; Yao WJ; Chang TT; Wang ST; Chou P
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2054-60. PubMed ID: 19549812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
    Yu MW; Yeh SH; Chen PJ; Liaw YF; Lin CL; Liu CJ; Shih WL; Kao JH; Chen DS; Chen CJ
    J Natl Cancer Inst; 2005 Feb; 97(4):265-72. PubMed ID: 15713961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiological and molecular profile of hepatocellular cancer from India.
    Asim M; Sarma MP; Kar P
    Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma.
    Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Batrla-Utermann R; Wang LY; You SL; Hsiao CK; Chen PJ; Chen CJ;
    Gut; 2014 Oct; 63(10):1648-57. PubMed ID: 24225939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma.
    Tsai FC; Liu CJ; Chen CL; Chen PJ; Lai MY; Kao JH; Chen DS
    J Viral Hepat; 2007 Mar; 14(3):153-60. PubMed ID: 17305880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
    Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
    J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
    Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
    Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.
    Tsai JF; Jeng JE; Ho MS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
    Br J Cancer; 1997; 76(7):968-74. PubMed ID: 9328161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.